SAN FRANCISCO—For colorectal cancer prevention, stool-based testing should be a first-line option rather than just an alternative to colonoscopy, according to Theodore R. Levin, MD, the clinical lead for colorectal cancer screening and the associate director for cancer research at the Kaiser Permanente Division of Research, in Oakland, Calif.
“Stool-based testing is particularly valuable for organized screening where you can do mailed outreach to a large population of patients.